- Rank375
- Previous Rank454
- CEOGeorge A. Scangos
- Address225 Binney St., Cambridge, MA 02142
- Websitewww.biogenidec.com
Key Financials
$ Millions | % change | |
---|---|---|
Revenues | 6,932 | 25.7 |
Profits | 1862 | 34.9 |
Total Assets | 11,863 | - |
Total Shareholder Equity | 8,620 | - |
Market Value (on March 31, 2014) | 72,305 | - |
Profit as a % of
Sales | 26.9 |
Assets | 15.7 |
Stockholders' Equity | 21.6 |
Earnings Per Share
Earnings Per Share ($) | 7.81 |
EPS % Change (from 2012) | 35.6 |
EPS % Change (5 year) | 24.1 |
EPS % Change (10 year) | - |
Total Return to Investors
Total Return to Investors | 91 |
Total Return to Investors (5 year, annualized) | 42.5 |
Total Return to Investors (10 year, annualized) | 22.5 |